REDUCE MRSA Trial Lead Author Discusses Landmark Paper in CDC's Healthcare Blog

News
Article

Today, on CDC's Safe Healthcare blog, lead author of the REDUCE MRSA trial, Dr. Susan Huang, discusses the results of the landmark study and provides insight into what the findings mean for infection prevention and patient safety.

The REDUCE MRSA trial found that using germ-killing soap and ointment on all intensive-care unit (ICU) patients could reduce bloodstream infections by up to 44 percent and significantly reduce the presence of methicillin-resistant Staphylococcus aureus (MRSA) in ICUs.

Huang is an associate professor at the University of California Irvine School of Medicine and medical director of epidemiology and infection prevention at UC Irvine Health.

Join the conversation by clicking HERE.

Recent Videos
Mark Wiencek, PhD
Rebecca Crapanzano-Sigafoos, DrPH, CIC, AL-CIP, FAPIC
The CDC’s updated hospital respiratory reporting requirement has added new layers of responsibility for infection preventionists. Karen Jones, MPH, RN, CIC, FAPIC, clinical program manager at Wolters Kluwer, breaks down what it means and how IPs can adapt.
Studying for the CIC using a digital tablet and computer (Adobe Stock 335828989 by NIKCOA)
Infection Control Today's Conversations with the HSPA President, Arlene Bush, CRCST, CER, CIS, SME, DSMD, CRMST
Infection Control Today's Conversations with the HSPA President, Arlene Bush, CRCST, CER, CIS, SME, DSMD, CRMST
Cheron Rojo, BS, FCS, CHL,  CER, CFER, CRCST
Matthias Tschoerner, Dr Sc
Standardizing Cleaning and Disinfection
Concept images of Far-UVC  (Adobe Stock 316993517 by hopenv)
Related Content